These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 39253182)

  • 21. Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study.
    Vrillon A; Mouton-Liger F; Martinet M; Cognat E; Hourregue C; Dumurgier J; Bouaziz-Amar E; Brinkmalm A; Blennow K; Zetterberg H; Hugon J; Paquet C
    Alzheimers Res Ther; 2022 May; 14(1):71. PubMed ID: 35606871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer.
    Estepa-Fernández A; García-Fernández A; Lérida-Viso A; Blandez JF; Galiana I; Sancenon-Galarza F; Orzáez M; Martínez-Máñez R
    Pharmacol Res; 2023 Jan; 187():106628. PubMed ID: 36566002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease.
    van Dyck CH; Mecca AP; O'Dell RS; Bartlett HH; Diepenbrock NG; Huang Y; Hamby ME; Grundman M; Catalano SM; Caggiano AO; Carson RE
    Alzheimers Res Ther; 2024 Jan; 16(1):20. PubMed ID: 38273408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Δ133p53α Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity.
    Ungerleider K; Beck JA; Lissa D; Joruiz S; Horikawa I; Harris CC
    Neuroscience; 2022 Aug; 498():190-202. PubMed ID: 35716965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.
    Simrén J; Brum WS; Ashton NJ; Benedet AL; Karikari TK; Kvartsberg H; Sjons E; Lussier FZ; Chamoun M; Stevenson J; Hopewell R; Pallen V; Ye K; Pascoal TA; Zetterberg H; Rosa-Neto P; Blennow K
    Alzheimers Res Ther; 2022 Dec; 14(1):192. PubMed ID: 36544221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers.
    Torres P; Anerillas C; Ramírez-Núñez O; Fernàndez A; Encinas M; Povedano M; Andrés-Benito P; Ferrer I; Ayala V; Pamplona R; Portero-Otín M
    Dis Model Mech; 2022 Aug; 15(8):. PubMed ID: 35916061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
    Ashton NJ; Brum WS; Di Molfetta G; Benedet AL; Arslan B; Jonaitis E; Langhough RE; Cody K; Wilson R; Carlsson CM; Vanmechelen E; Montoliu-Gaya L; Lantero-Rodriguez J; Rahmouni N; Tissot C; Stevenson J; Servaes S; Therriault J; Pascoal T; Lleó A; Alcolea D; Fortea J; Rosa-Neto P; Johnson S; Jeromin A; Blennow K; Zetterberg H
    JAMA Neurol; 2024 Mar; 81(3):255-263. PubMed ID: 38252443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
    Milà-Alomà M; Brinkmalm A; Ashton NJ; Kvartsberg H; Shekari M; Operto G; Salvadó G; Falcon C; Gispert JD; Vilor-Tejedor N; Arenaza-Urquijo EM; Grau-Rivera O; Sala-Vila A; Sanchez-Benavides G; González-de-Echávarri JM; Minguillon C; Fauria K; Niñerola-Baizán A; Perissinotti A; Kollmorgen G; Suridjan I; Zetterberg H; Molinuevo JL; Blennow K; Suárez-Calvet M;
    Neurology; 2021 Nov; 97(21):e2065-e2078. PubMed ID: 34556565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial.
    Gonzales MM; Garbarino VR; Marques Zilli E; Petersen RC; Kirkland JL; Tchkonia T; Musi N; Seshadri S; Craft S; Orr ME
    J Prev Alzheimers Dis; 2022; 9(1):22-29. PubMed ID: 35098970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases.
    Wissler Gerdes EO; Zhu Y; Weigand BM; Tripathi U; Burns TC; Tchkonia T; Kirkland JL
    Int Rev Neurobiol; 2020; 155():203-234. PubMed ID: 32854855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
    Zhang H; Lyu D; Jia J;
    J Alzheimers Dis; 2022; 85(4):1441-1452. PubMed ID: 34958042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
    Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
    ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.
    Forny-Germano L; Lyra e Silva NM; Batista AF; Brito-Moreira J; Gralle M; Boehnke SE; Coe BC; Lablans A; Marques SA; Martinez AM; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Neurosci; 2014 Oct; 34(41):13629-43. PubMed ID: 25297091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
    Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
    Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nonhuman primate model with Alzheimer's disease-like pathology induced by hippocampal overexpression of human tau.
    Jiang Z; Wang J; Qin Y; Liu S; Luo B; Bai F; Wei H; Zhang S; Wei J; Ding G; Ma L; He S; Chen R; Sun Y; Chen Y; Wang L; Xu H; Wang X; Chen G; Lei W
    Alzheimers Res Ther; 2024 Jan; 16(1):22. PubMed ID: 38281031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.
    Guo T; Landau SM; Jagust WJ;
    Alzheimers Res Ther; 2021 Oct; 13(1):174. PubMed ID: 34654465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies.
    Gaikwad S; Senapati S; Haque MA; Kayed R
    Alzheimers Dement; 2024 Jan; 20(1):709-727. PubMed ID: 37814508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.